Federal Circuit upholds AzaSite eye drop patents

14-04-2015

The US Court of Appeals for the Federal Circuit has upheld the validity of four patents covering conjunctivitis treatment AzaSite (azithromycin ophthalmic solution).


US Court of Appeals for the Federal Circuit, AzaSite, InSite, Pfizer, ANDA

LSIPR